data_6ovj_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6ovj _Structure_validation_residue.Date_analyzed 2020-05-01 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.905 0.383 . . . . 62.32 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.5 p -111.35 32.26 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.34 49.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 75.42 110.92 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -31.39 20.84 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.694 2.263 . . . . 63.43 112.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 -32.56 47.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 75.35 111.067 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.26 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.891 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.77 -165.87 34.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 65.02 112.48 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -174.56 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.677 2.251 . . . . 74.23 112.35 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.891 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.8 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.874 0.369 . . . . 62.32 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.2 p -111.28 32.36 5.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.19 161.48 49.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.594 0.712 . . . . 75.42 110.945 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 -31.28 20.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 63.43 112.326 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.0 -32.38 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.35 111.086 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.35 -30.64 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 73.43 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.61 -166.75 33.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.773 -0.727 . . . . 65.02 112.523 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 74.23 112.389 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 74.12 110.934 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.2 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.891 0.377 . . . . 62.32 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.6 p -111.27 32.39 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.867 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.36 49.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 75.42 110.84 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -31.38 20.97 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.673 2.249 . . . . 63.43 112.382 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.97 -32.54 45.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 75.35 111.069 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.19 -30.86 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 73.43 110.861 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.35 -165.88 35.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 65.02 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -171.82 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.23 112.362 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.878 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.0 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.844 0.354 . . . . 62.32 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 t -111.17 32.3 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.43 110.883 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.17 161.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.727 . . . . 75.42 110.853 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -31.28 20.74 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.257 . . . . 63.43 112.394 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.06 -32.51 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 75.35 111.094 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.18 -30.78 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 73.43 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.51 -165.74 33.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 65.02 112.516 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -174.69 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.658 2.239 . . . . 74.23 112.285 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p30 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 74.12 110.922 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.852 0.358 . . . . 62.32 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.3 p -111.13 32.3 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 75.43 110.904 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -86.22 161.45 49.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 75.42 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.33 20.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 63.43 112.411 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.54 44.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 75.35 111.116 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.869 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.63 -165.88 33.65 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 65.02 112.52 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 -177.66 2.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.659 2.239 . . . . 74.23 112.351 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 74.12 110.923 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.0 t . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.816 0.341 . . . . 62.32 110.84 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.9 t -111.03 32.22 5.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 75.43 110.867 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.09 161.34 49.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.7 0.762 . . . . 75.42 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -31.32 20.88 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.702 2.268 . . . . 63.43 112.37 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.43 44.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 75.35 111.155 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.39 -30.65 71.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 73.43 110.851 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.63 -165.95 32.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 65.02 112.468 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -171.49 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 74.23 112.347 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p30 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.975 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.924 0.393 . . . . 62.32 110.902 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 t -111.07 32.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.888 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.14 161.44 49.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 75.42 110.873 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.31 20.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 63.43 112.301 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.28 -32.48 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 75.35 111.075 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.21 -30.86 71.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 73.43 110.856 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.58 -165.7 32.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 65.02 112.482 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -173.42 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.637 2.224 . . . . 74.23 112.354 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.953 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.85 0.357 . . . . 62.32 110.841 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.5 p -111.09 32.41 5.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 75.43 110.853 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.26 161.42 49.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.682 0.753 . . . . 75.42 110.858 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -31.39 20.9 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.664 2.243 . . . . 63.43 112.359 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.21 -32.54 44.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 75.35 111.122 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.17 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 73.43 110.892 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.59 -165.76 33.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 65.02 112.55 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -173.58 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.66 2.24 . . . . 74.23 112.343 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.941 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.882 0.372 . . . . 62.32 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.7 t -110.96 32.41 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.43 110.884 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.27 161.35 49.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.697 0.76 . . . . 75.42 110.833 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.67 -31.39 21.01 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.646 2.23 . . . . 63.43 112.378 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.57 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 75.35 111.109 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.22 -30.79 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.86 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.54 -166.36 35.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 65.02 112.468 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 74.23 112.381 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 74.12 110.884 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.2 t . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.808 0.337 . . . . 62.32 110.9 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.0 p -111.14 32.31 5.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.44 49.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 75.42 110.892 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -31.35 20.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.728 2.285 . . . . 63.43 112.308 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.18 -32.52 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 75.35 111.078 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.72 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.893 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.97 -165.71 33.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 65.02 112.494 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 -173.19 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.699 2.266 . . . . 74.23 112.305 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.922 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.942 0.401 . . . . 62.32 110.911 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t -111.05 32.32 5.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.875 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.38 49.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.552 0.692 . . . . 75.42 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.65 -31.31 21.28 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.781 2.321 . . . . 63.43 112.381 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.38 -32.43 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 75.35 111.059 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.76 71.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.903 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.36 -166.11 35.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 65.02 112.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -170.93 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.738 2.292 . . . . 74.23 112.352 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 74.12 110.872 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.911 0.386 . . . . 62.32 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.1 p -110.32 32.43 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.798 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.21 161.39 49.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.655 0.741 . . . . 75.42 110.897 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -31.21 20.65 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 63.43 112.32 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.42 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 75.35 111.065 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -30.86 71.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 73.43 110.82 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.8 -165.65 30.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 65.02 112.455 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.628 2.219 . . . . 74.23 112.356 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 p30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 74.12 110.839 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.787 0.327 . . . . 62.32 110.923 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.8 p -110.26 32.28 5.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.882 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.16 161.57 48.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 75.42 110.914 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -31.13 20.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 2.253 . . . . 63.43 112.31 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.58 -32.51 36.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 75.35 111.13 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.77 71.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 73.43 110.861 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.46 -165.5 34.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 65.02 112.479 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.88 0.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.735 2.29 . . . . 74.23 112.408 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m120 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.326 -0.397 . . . . 74.12 110.93 179.974 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.824 0.345 . . . . 62.32 110.888 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m -108.75 31.95 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.812 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.2 161.44 49.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 75.42 110.992 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.16 20.93 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 63.43 112.316 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.07 -32.55 30.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 75.35 111.057 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.19 -30.85 71.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.43 110.87 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.9 -165.35 30.64 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.792 -0.718 . . . . 65.02 112.519 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.268 . . . . 74.23 112.375 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 74.12 110.865 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.831 0.348 . . . . 62.32 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.3 p -108.86 32.28 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.908 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.11 161.62 48.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 75.42 110.846 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -30.96 21.49 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.711 2.274 . . . . 63.43 112.323 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.69 -32.45 28.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.35 111.03 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -30.92 71.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 73.43 110.869 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -165.19 34.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 65.02 112.453 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -170.82 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 74.23 112.333 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.878 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.1 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.832 0.348 . . . . 62.32 110.916 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 p -108.92 32.4 4.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.891 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.21 161.65 48.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.646 0.736 . . . . 75.42 110.88 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -30.94 21.76 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.718 2.279 . . . . 63.43 112.368 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.6 -32.36 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.101 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.32 -30.71 71.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 73.43 110.864 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 -165.04 34.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.737 . . . . 65.02 112.509 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -170.77 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.65 2.234 . . . . 74.23 112.349 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.902 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.795 0.331 . . . . 62.32 110.912 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.0 p -108.86 32.41 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.838 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.17 161.73 48.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.611 0.719 . . . . 75.42 110.85 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -30.85 21.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 63.43 112.379 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.73 -32.51 27.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.35 111.092 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.845 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.5 -165.06 34.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 65.02 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -170.73 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 74.23 112.354 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 74.12 110.82 -179.967 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.938 0.399 . . . . 62.32 110.947 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -109.0 32.46 4.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.828 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.25 161.75 48.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.739 . . . . 75.42 110.899 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -31.08 21.52 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.742 2.295 . . . . 63.43 112.383 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.67 -32.32 28.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 75.35 111.082 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.41 -30.72 71.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.861 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.53 -164.96 34.29 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 65.02 112.444 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -170.88 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.663 2.242 . . . . 74.23 112.362 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.926 179.943 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.866 0.365 . . . . 62.32 110.87 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.2 p -108.78 32.24 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.13 161.66 48.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.65 0.738 . . . . 75.42 110.881 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.92 21.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 63.43 112.313 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.79 -32.36 27.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 75.35 111.112 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.21 -30.91 71.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.894 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.22 -165.01 34.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 65.02 112.461 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.671 2.247 . . . . 74.23 112.346 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.85 -179.976 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.885 0.374 . . . . 62.32 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.4 p -108.14 31.81 5.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.927 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -85.94 162.07 48.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.586 0.708 . . . . 75.42 110.902 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -30.02 23.23 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.735 2.29 . . . . 63.43 112.325 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.62 -33.3 25.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 75.35 111.076 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -65.47 -30.88 71.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 73.43 110.864 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.67 -164.17 35.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 65.02 112.448 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 74.23 112.349 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.856 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 56.1 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.898 0.38 . . . . 71.5 111.133 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.8 t -84.31 114.53 21.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 62.32 110.879 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.5 p -111.35 32.26 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.34 49.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 75.42 110.92 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -31.39 20.84 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.694 2.263 . . . . 63.43 112.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 -32.56 47.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 75.35 111.067 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.26 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.891 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.77 -165.87 34.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 65.02 112.48 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -174.56 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.677 2.251 . . . . 74.23 112.35 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -53.09 115.37 1.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.891 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -119.3 155.74 31.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 73.4 110.894 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.78 87.47 0.54 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 63.41 112.491 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 75.24 110.878 -179.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 31.9 mt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.843 0.354 . . . . 71.5 111.057 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.8 t -79.19 114.5 18.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 62.32 110.917 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.2 p -111.28 32.36 5.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.19 161.48 49.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.594 0.712 . . . . 75.42 110.945 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 -31.28 20.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 63.43 112.326 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.0 -32.38 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.35 111.086 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.35 -30.64 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 73.43 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.61 -166.75 33.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.773 -0.727 . . . . 65.02 112.523 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 74.23 112.389 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -52.01 127.97 23.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 74.12 110.934 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -130.25 159.05 38.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.866 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.2 82.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 63.41 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 75.24 110.891 -179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.913 0.387 . . . . 71.5 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.2 t -84.03 114.52 21.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 62.32 110.875 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.6 p -111.27 32.39 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.867 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.36 49.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 75.42 110.84 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -31.38 20.97 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.673 2.249 . . . . 63.43 112.382 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.97 -32.54 45.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 75.35 111.069 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.19 -30.86 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 73.43 110.861 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.35 -165.88 35.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 65.02 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -171.82 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.23 112.362 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -52.19 114.96 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.878 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -119.63 169.93 9.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.834 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 88.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 63.41 112.479 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 75.24 110.907 -179.922 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 55.0 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.863 0.363 . . . . 71.5 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.0 t -76.9 114.46 15.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 62.32 110.923 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 t -111.17 32.3 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.43 110.883 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.17 161.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.727 . . . . 75.42 110.853 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -31.28 20.74 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.257 . . . . 63.43 112.394 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.06 -32.51 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 75.35 111.094 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.18 -30.78 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 73.43 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.51 -165.74 33.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 65.02 112.516 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -174.69 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.658 2.239 . . . . 74.23 112.285 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -52.11 116.12 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 74.12 110.922 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -100.21 171.43 7.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.49 . . . . 73.4 110.92 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.89 75.7 2.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.801 -0.714 . . . . 63.41 112.513 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 75.24 110.861 -179.876 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 37.5 mm . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.927 0.394 . . . . 71.5 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t -84.72 114.57 22.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 62.32 110.893 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.3 p -111.13 32.3 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 75.43 110.904 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -86.22 161.45 49.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 75.42 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.33 20.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 63.43 112.411 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.54 44.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 75.35 111.116 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.869 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.63 -165.88 33.65 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 65.02 112.52 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 -177.66 2.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.659 2.239 . . . . 74.23 112.351 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -51.97 118.88 3.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 74.12 110.923 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -121.1 162.83 19.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 73.4 110.925 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.18 77.18 1.71 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.725 . . . . 63.41 112.503 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 75.24 110.834 -179.845 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 32.1 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.929 0.395 . . . . 71.5 111.145 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.0 t -77.05 114.5 15.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 62.32 110.84 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.9 t -111.03 32.22 5.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 75.43 110.867 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.09 161.34 49.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.7 0.762 . . . . 75.42 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -31.32 20.88 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.702 2.268 . . . . 63.43 112.37 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.43 44.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 75.35 111.155 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.39 -30.65 71.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 73.43 110.851 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.63 -165.95 32.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 65.02 112.468 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -171.49 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 74.23 112.347 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -52.21 116.52 2.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.975 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.94 171.66 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.886 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.3 61.61 4.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.781 -0.723 . . . . 63.41 112.512 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 75.24 110.845 -179.842 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.874 0.369 . . . . 71.5 111.211 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.8 t -83.32 114.58 21.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 62.32 110.902 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 t -111.07 32.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.888 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.14 161.44 49.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 75.42 110.873 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.31 20.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 63.43 112.301 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.28 -32.48 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 75.35 111.075 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.21 -30.86 71.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 73.43 110.856 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.58 -165.7 32.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 65.02 112.482 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -173.42 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.637 2.224 . . . . 74.23 112.354 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -52.12 125.84 16.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -107.56 173.07 6.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 73.4 110.908 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.08 58.19 4.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 63.41 112.441 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.1 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.762 0.315 . . . . 75.24 110.857 -179.876 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.914 0.388 . . . . 71.5 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -74.9 114.47 13.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 62.32 110.841 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.5 p -111.09 32.41 5.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 75.43 110.853 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.26 161.42 49.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.682 0.753 . . . . 75.42 110.858 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -31.39 20.9 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.664 2.243 . . . . 63.43 112.359 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.21 -32.54 44.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 75.35 111.122 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.17 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 73.43 110.892 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.59 -165.76 33.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 65.02 112.55 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -173.58 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.66 2.24 . . . . 74.23 112.343 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -52.02 135.4 31.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.941 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -139.32 162.01 36.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 73.4 110.953 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.5 73.55 1.83 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.753 -0.737 . . . . 63.41 112.48 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.757 0.313 . . . . 75.24 110.886 -179.893 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.5 pt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.898 0.38 . . . . 71.5 111.093 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -52.26 114.44 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.885 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.7 t -110.96 32.41 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.43 110.884 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.27 161.35 49.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.697 0.76 . . . . 75.42 110.833 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.67 -31.39 21.01 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.646 2.23 . . . . 63.43 112.378 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.57 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 75.35 111.109 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.22 -30.79 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.86 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.54 -166.36 35.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 65.02 112.468 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 74.23 112.381 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -52.27 103.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 74.12 110.884 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -98.28 178.56 5.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 73.4 110.956 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.36 90.11 0.15 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 63.41 112.473 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.69 0.281 . . . . 75.24 110.885 -179.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 39.9 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.937 0.398 . . . . 71.5 111.192 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.2 t -82.51 114.52 20.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 62.32 110.9 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.0 p -111.14 32.31 5.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.44 49.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 75.42 110.892 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -31.35 20.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.728 2.285 . . . . 63.43 112.308 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.18 -32.52 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 75.35 111.078 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.72 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.893 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.97 -165.71 33.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 65.02 112.494 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 -173.19 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.699 2.266 . . . . 74.23 112.305 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -52.15 147.4 7.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.922 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -154.98 163.83 39.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 73.4 110.872 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.21 85.51 1.02 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.67 -0.776 . . . . 63.41 112.525 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 75.24 110.943 -179.883 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.4 pt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.888 0.375 . . . . 71.5 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.9 t -51.98 114.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 62.32 110.911 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t -111.05 32.32 5.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.875 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.38 49.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.552 0.692 . . . . 75.42 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.65 -31.31 21.28 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.781 2.321 . . . . 63.43 112.381 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.38 -32.43 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 75.35 111.059 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.76 71.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.903 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.36 -166.11 35.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 65.02 112.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -170.93 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.738 2.292 . . . . 74.23 112.352 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -52.01 103.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 74.12 110.872 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -98.3 177.88 5.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 73.4 110.94 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.16 90.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.739 . . . . 63.41 112.532 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 75.24 110.914 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.887 0.375 . . . . 71.5 111.139 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t -64.43 114.56 4.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 62.32 110.904 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.1 p -110.32 32.43 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.798 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.21 161.39 49.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.655 0.741 . . . . 75.42 110.897 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -31.21 20.65 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 63.43 112.32 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.42 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 75.35 111.065 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -30.86 71.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 73.43 110.82 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.8 -165.65 30.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 65.02 112.455 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.628 2.219 . . . . 74.23 112.356 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -52.06 135.13 31.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 74.12 110.839 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -139.87 171.79 13.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 73.4 110.878 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.25 74.87 2.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 63.41 112.508 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.341 . . . . 75.24 110.869 -179.866 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 27.7 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.817 0.341 . . . . 71.5 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t -86.05 114.53 23.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.923 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.8 p -110.26 32.28 5.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.882 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.16 161.57 48.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 75.42 110.914 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -31.13 20.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 2.253 . . . . 63.43 112.31 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.58 -32.51 36.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 75.35 111.13 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.77 71.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 73.43 110.861 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.46 -165.5 34.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 65.02 112.479 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.88 0.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.735 2.29 . . . . 74.23 112.408 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -51.91 143.56 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.326 -0.397 . . . . 74.12 110.93 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -143.65 172.5 12.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 73.4 110.906 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.37 -46.62 92.76 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.715 -0.755 . . . . 63.41 112.48 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 75.24 110.89 -179.858 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.926 0.393 . . . . 71.5 111.123 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t -66.32 114.59 5.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.888 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m -108.75 31.95 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.812 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.2 161.44 49.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 75.42 110.992 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.16 20.93 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 63.43 112.316 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.07 -32.55 30.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 75.35 111.057 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.19 -30.85 71.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.43 110.87 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.9 -165.35 30.64 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.792 -0.718 . . . . 65.02 112.519 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.268 . . . . 74.23 112.375 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -52.13 153.56 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 74.12 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -133.64 179.15 6.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 73.4 110.953 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.17 75.36 1.57 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.684 -0.77 . . . . 63.41 112.501 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 75.24 110.823 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 28.7 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.929 0.395 . . . . 71.5 111.146 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.65 114.49 23.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 62.32 110.909 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.3 p -108.86 32.28 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.908 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.11 161.62 48.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 75.42 110.846 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -30.96 21.49 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.711 2.274 . . . . 63.43 112.323 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.69 -32.45 28.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.35 111.03 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -30.92 71.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 73.43 110.869 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -165.19 34.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 65.02 112.453 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -170.82 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 74.23 112.333 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -51.76 135.55 29.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.878 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -133.24 166.09 23.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 73.4 110.912 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.64 77.77 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 63.41 112.514 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.0 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 75.24 110.891 -179.883 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 32.5 mm . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.852 0.358 . . . . 71.5 111.13 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.1 t -86.39 114.45 23.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 62.32 110.916 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 p -108.92 32.4 4.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.891 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.21 161.65 48.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.646 0.736 . . . . 75.42 110.88 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -30.94 21.76 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.718 2.279 . . . . 63.43 112.368 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.6 -32.36 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.101 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.32 -30.71 71.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 73.43 110.864 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 -165.04 34.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.737 . . . . 65.02 112.509 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -170.77 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.65 2.234 . . . . 74.23 112.349 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -51.87 135.91 29.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.902 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -132.89 166.91 21.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 73.4 110.925 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.76 77.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.759 -0.734 . . . . 63.41 112.456 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 75.24 110.856 -179.876 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 42.4 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.831 0.348 . . . . 71.5 111.149 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.5 t -85.78 114.44 22.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 62.32 110.912 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.0 p -108.86 32.41 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.838 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.17 161.73 48.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.611 0.719 . . . . 75.42 110.85 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -30.85 21.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 63.43 112.379 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.73 -32.51 27.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.35 111.092 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.845 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.5 -165.06 34.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 65.02 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -170.73 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 74.23 112.354 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -51.85 138.6 23.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 74.12 110.82 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -136.11 166.72 22.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 73.4 110.917 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.63 77.62 0.23 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 63.41 112.495 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.6 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 75.24 110.894 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.6 mm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.906 0.384 . . . . 71.5 111.175 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t -86.36 114.55 23.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 62.32 110.947 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -109.0 32.46 4.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.828 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.25 161.75 48.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.739 . . . . 75.42 110.899 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -31.08 21.52 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.742 2.295 . . . . 63.43 112.383 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.67 -32.32 28.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 75.35 111.082 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.41 -30.72 71.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.861 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.53 -164.96 34.29 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 65.02 112.444 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -170.88 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.663 2.242 . . . . 74.23 112.362 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -51.76 140.02 20.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.926 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.42 165.66 26.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.928 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.76 77.38 0.23 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 63.41 112.506 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.8 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 75.24 110.874 -179.878 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.869 0.366 . . . . 71.5 111.164 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.68 114.52 23.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 62.32 110.87 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.2 p -108.78 32.24 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.13 161.66 48.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.65 0.738 . . . . 75.42 110.881 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.92 21.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 63.43 112.313 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.79 -32.36 27.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 75.35 111.112 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.21 -30.91 71.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.894 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.22 -165.01 34.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 65.02 112.461 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.671 2.247 . . . . 74.23 112.346 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -51.86 133.67 31.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.85 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -131.75 163.2 28.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 73.4 110.976 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.68 79.26 0.27 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.724 -0.75 . . . . 63.41 112.5 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.4 p . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.319 . . . . 75.24 110.923 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.907 0.384 . . . . 71.5 111.114 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.6 t -84.36 114.41 21.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 62.32 110.881 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.4 p -108.14 31.81 5.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.927 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -85.94 162.07 48.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.586 0.708 . . . . 75.42 110.902 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -30.02 23.23 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.735 2.29 . . . . 63.43 112.325 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.62 -33.3 25.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 75.35 111.076 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -65.47 -30.88 71.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 73.43 110.864 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.67 -164.17 35.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 65.02 112.448 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 74.23 112.349 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -51.75 141.19 17.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.856 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -148.98 151.7 35.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 73.4 110.934 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.27 88.74 0.5 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 63.41 112.506 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 75.24 110.901 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.905 0.383 . . . . 62.32 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.5 p -111.35 32.26 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.34 49.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 74.33 110.92 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -31.39 20.84 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.694 2.263 . . . . 63.32 112.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 -32.56 47.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 74.14 111.067 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.26 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 72.21 110.891 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.77 -165.87 34.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 65.02 112.48 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -174.56 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.677 2.251 . . . . 74.23 112.35 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.891 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.8 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.874 0.369 . . . . 62.32 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.2 p -111.28 32.36 5.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.19 161.48 49.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.594 0.712 . . . . 74.33 110.945 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 -31.28 20.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 63.32 112.326 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.0 -32.38 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.086 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.35 -30.64 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.61 -166.75 33.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.773 -0.727 . . . . 65.02 112.523 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 74.23 112.389 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 74.12 110.934 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.2 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.891 0.377 . . . . 62.32 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.6 p -111.27 32.39 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.867 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.36 49.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 74.33 110.84 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -31.38 20.97 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.673 2.249 . . . . 63.32 112.382 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.97 -32.54 45.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 74.14 111.069 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.19 -30.86 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 72.21 110.861 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.35 -165.88 35.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 65.02 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -171.82 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.23 112.362 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.878 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.0 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.844 0.354 . . . . 62.32 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 t -111.17 32.3 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.43 110.883 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.17 161.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.727 . . . . 74.33 110.853 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -31.28 20.74 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.257 . . . . 63.32 112.394 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.06 -32.51 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.14 111.094 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.18 -30.78 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 72.21 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.51 -165.74 33.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 65.02 112.516 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -174.69 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.658 2.239 . . . . 74.23 112.285 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p30 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 74.12 110.922 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.852 0.358 . . . . 62.32 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.3 p -111.13 32.3 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 75.43 110.904 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -86.22 161.45 49.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 74.33 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.33 20.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 63.32 112.411 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.54 44.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.116 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 72.21 110.869 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.63 -165.88 33.65 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 65.02 112.52 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 -177.66 2.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.659 2.239 . . . . 74.23 112.351 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 74.12 110.923 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.0 t . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.816 0.341 . . . . 62.32 110.84 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.9 t -111.03 32.22 5.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 75.43 110.867 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.09 161.34 49.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.7 0.762 . . . . 74.33 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -31.32 20.88 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.702 2.268 . . . . 63.32 112.37 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.43 44.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 74.14 111.155 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.39 -30.65 71.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 72.21 110.851 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.63 -165.95 32.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 65.02 112.468 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -171.49 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 74.23 112.347 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p30 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.975 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.924 0.393 . . . . 62.32 110.902 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 t -111.07 32.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.888 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.14 161.44 49.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 74.33 110.873 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.31 20.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 63.32 112.301 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.28 -32.48 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 74.14 111.075 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.21 -30.86 71.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 72.21 110.856 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.58 -165.7 32.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 65.02 112.482 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -173.42 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.637 2.224 . . . . 74.23 112.354 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.953 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.85 0.357 . . . . 62.32 110.841 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.5 p -111.09 32.41 5.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 75.43 110.853 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.26 161.42 49.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.682 0.753 . . . . 74.33 110.858 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -31.39 20.9 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.664 2.243 . . . . 63.32 112.359 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.21 -32.54 44.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.122 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.17 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 72.21 110.892 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.59 -165.76 33.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 65.02 112.55 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -173.58 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.66 2.24 . . . . 74.23 112.343 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.941 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.882 0.372 . . . . 62.32 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.7 t -110.96 32.41 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.43 110.884 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.27 161.35 49.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.697 0.76 . . . . 74.33 110.833 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.67 -31.39 21.01 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.646 2.23 . . . . 63.32 112.378 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.57 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 74.14 111.109 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.22 -30.79 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.21 110.86 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.54 -166.36 35.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 65.02 112.468 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 74.23 112.381 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 74.12 110.884 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.2 t . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.808 0.337 . . . . 62.32 110.9 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.0 p -111.14 32.31 5.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.44 49.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 74.33 110.892 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -31.35 20.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.728 2.285 . . . . 63.32 112.308 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.18 -32.52 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 74.14 111.078 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.72 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.893 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.97 -165.71 33.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 65.02 112.494 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 -173.19 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.699 2.266 . . . . 74.23 112.305 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.0 p30 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.922 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.942 0.401 . . . . 62.32 110.911 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t -111.05 32.32 5.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.875 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.38 49.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.552 0.692 . . . . 74.33 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.65 -31.31 21.28 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.781 2.321 . . . . 63.32 112.381 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.38 -32.43 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.059 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.76 71.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 72.21 110.903 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.36 -166.11 35.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 65.02 112.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -170.93 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.738 2.292 . . . . 74.23 112.352 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 74.12 110.872 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.911 0.386 . . . . 62.32 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.1 p -110.32 32.43 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.798 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.21 161.39 49.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.655 0.741 . . . . 74.33 110.897 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -31.21 20.65 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 63.32 112.32 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.42 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 74.14 111.065 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -30.86 71.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 72.21 110.82 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.8 -165.65 30.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 65.02 112.455 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.628 2.219 . . . . 74.23 112.356 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 p30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 74.12 110.839 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.787 0.327 . . . . 62.32 110.923 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.8 p -110.26 32.28 5.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.882 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.16 161.57 48.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 74.33 110.914 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -31.13 20.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 2.253 . . . . 63.32 112.31 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.58 -32.51 36.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 74.14 111.13 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.77 71.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 72.21 110.861 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.46 -165.5 34.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 65.02 112.479 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.88 0.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.735 2.29 . . . . 74.23 112.408 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m120 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.326 -0.397 . . . . 74.12 110.93 179.974 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.824 0.345 . . . . 62.32 110.888 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m -108.75 31.95 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.812 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.2 161.44 49.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 74.33 110.992 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.16 20.93 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 63.32 112.316 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.07 -32.55 30.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.14 111.057 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.19 -30.85 71.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.87 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.9 -165.35 30.64 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.792 -0.718 . . . . 65.02 112.519 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.268 . . . . 74.23 112.375 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 74.12 110.865 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.831 0.348 . . . . 62.32 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.3 p -108.86 32.28 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.908 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.11 161.62 48.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 74.33 110.846 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -30.96 21.49 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.711 2.274 . . . . 63.32 112.323 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.69 -32.45 28.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 74.14 111.03 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -30.92 71.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 72.21 110.869 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -165.19 34.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 65.02 112.453 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -170.82 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 74.23 112.333 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.878 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.1 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.832 0.348 . . . . 62.32 110.916 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 p -108.92 32.4 4.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.891 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.21 161.65 48.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.646 0.736 . . . . 74.33 110.88 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -30.94 21.76 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.718 2.279 . . . . 63.32 112.368 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.6 -32.36 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.101 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.32 -30.71 71.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 72.21 110.864 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 -165.04 34.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.737 . . . . 65.02 112.509 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -170.77 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.65 2.234 . . . . 74.23 112.349 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.902 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.795 0.331 . . . . 62.32 110.912 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.0 p -108.86 32.41 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.838 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.17 161.73 48.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.611 0.719 . . . . 74.33 110.85 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -30.85 21.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 63.32 112.379 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.73 -32.51 27.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 74.14 111.092 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.845 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.5 -165.06 34.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 65.02 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -170.73 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 74.23 112.354 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 74.12 110.82 -179.967 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.938 0.399 . . . . 62.32 110.947 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -109.0 32.46 4.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.828 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.25 161.75 48.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.739 . . . . 74.33 110.899 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -31.08 21.52 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.742 2.295 . . . . 63.32 112.383 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.67 -32.32 28.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.14 111.082 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.41 -30.72 71.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 72.21 110.861 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.53 -164.96 34.29 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 65.02 112.444 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -170.88 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.663 2.242 . . . . 74.23 112.362 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.926 179.943 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.866 0.365 . . . . 62.32 110.87 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.2 p -108.78 32.24 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.13 161.66 48.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.65 0.738 . . . . 74.33 110.881 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.92 21.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 63.32 112.313 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.79 -32.36 27.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 74.14 111.112 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.21 -30.91 71.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.894 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.22 -165.01 34.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 65.02 112.461 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.671 2.247 . . . . 74.23 112.346 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.85 -179.976 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.885 0.374 . . . . 62.32 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.4 p -108.14 31.81 5.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.927 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -85.94 162.07 48.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.586 0.708 . . . . 74.33 110.902 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -30.02 23.23 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.735 2.29 . . . . 63.32 112.325 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.62 -33.3 25.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.076 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -65.47 -30.88 71.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 72.21 110.864 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.67 -164.17 35.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 65.02 112.448 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 74.23 112.349 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.856 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 56.1 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.898 0.38 . . . . 71.5 111.133 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.8 t -84.31 114.53 21.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 62.32 110.879 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.5 p -111.35 32.26 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.34 49.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 74.33 110.92 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -31.39 20.84 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.694 2.263 . . . . 63.32 112.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 -32.56 47.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 74.14 111.067 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.26 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 72.21 110.891 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.77 -165.87 34.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 65.02 112.48 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -174.56 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.677 2.251 . . . . 74.23 112.35 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -53.09 115.37 1.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.891 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -119.3 155.74 31.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 73.4 110.894 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.78 87.47 0.54 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 55.53 112.491 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 75.24 110.878 -179.904 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 31.9 mt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.843 0.354 . . . . 71.5 111.057 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.8 t -79.19 114.5 18.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 62.32 110.917 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.2 p -111.28 32.36 5.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.19 161.48 49.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.594 0.712 . . . . 74.33 110.945 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 -31.28 20.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 63.32 112.326 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.0 -32.38 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.086 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.35 -30.64 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.61 -166.75 33.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.773 -0.727 . . . . 65.02 112.523 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 74.23 112.389 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -52.01 127.97 23.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 74.12 110.934 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -130.25 159.05 38.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.866 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.2 82.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 55.53 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 75.24 110.891 -179.911 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.913 0.387 . . . . 71.5 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.2 t -84.03 114.52 21.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 62.32 110.875 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.6 p -111.27 32.39 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.867 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.36 49.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 74.33 110.84 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -31.38 20.97 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.673 2.249 . . . . 63.32 112.382 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.97 -32.54 45.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 74.14 111.069 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.19 -30.86 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 72.21 110.861 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.35 -165.88 35.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 65.02 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -171.82 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.23 112.362 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -52.19 114.96 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.878 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -119.63 169.93 9.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.834 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 88.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 55.53 112.479 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 75.24 110.907 -179.922 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 55.0 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.863 0.363 . . . . 71.5 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.0 t -76.9 114.46 15.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 62.32 110.923 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 t -111.17 32.3 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.43 110.883 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.17 161.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.727 . . . . 74.33 110.853 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -31.28 20.74 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.257 . . . . 63.32 112.394 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.06 -32.51 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.14 111.094 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.18 -30.78 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 72.21 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.51 -165.74 33.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 65.02 112.516 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -174.69 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.658 2.239 . . . . 74.23 112.285 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -52.11 116.12 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 74.12 110.922 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -100.21 171.43 7.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.49 . . . . 73.4 110.92 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.89 75.7 2.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.801 -0.714 . . . . 55.53 112.513 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 75.24 110.861 -179.876 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 37.5 mm . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.927 0.394 . . . . 71.5 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t -84.72 114.57 22.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 62.32 110.893 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.3 p -111.13 32.3 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 75.43 110.904 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -86.22 161.45 49.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 74.33 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.33 20.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 63.32 112.411 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.54 44.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.116 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 72.21 110.869 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.63 -165.88 33.65 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 65.02 112.52 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 -177.66 2.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.659 2.239 . . . . 74.23 112.351 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -51.97 118.88 3.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 74.12 110.923 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -121.1 162.83 19.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 73.4 110.925 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.18 77.18 1.71 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.725 . . . . 55.53 112.503 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 75.24 110.834 -179.845 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 32.1 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.929 0.395 . . . . 71.5 111.145 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.0 t -77.05 114.5 15.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 62.32 110.84 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.9 t -111.03 32.22 5.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 75.43 110.867 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.09 161.34 49.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.7 0.762 . . . . 74.33 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -31.32 20.88 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.702 2.268 . . . . 63.32 112.37 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.43 44.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 74.14 111.155 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.39 -30.65 71.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 72.21 110.851 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.63 -165.95 32.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 65.02 112.468 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -171.49 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 74.23 112.347 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -52.21 116.52 2.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.975 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.94 171.66 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.886 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.3 61.61 4.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.781 -0.723 . . . . 55.53 112.512 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 75.24 110.845 -179.842 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.874 0.369 . . . . 71.5 111.211 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.8 t -83.32 114.58 21.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 62.32 110.902 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 t -111.07 32.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.888 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.14 161.44 49.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 74.33 110.873 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.31 20.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 63.32 112.301 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.28 -32.48 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 74.14 111.075 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.21 -30.86 71.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 72.21 110.856 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.58 -165.7 32.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 65.02 112.482 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -173.42 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.637 2.224 . . . . 74.23 112.354 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -52.12 125.84 16.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -107.56 173.07 6.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 73.4 110.908 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.08 58.19 4.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 55.53 112.441 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.1 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.762 0.315 . . . . 75.24 110.857 -179.876 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.914 0.388 . . . . 71.5 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -74.9 114.47 13.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 62.32 110.841 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.5 p -111.09 32.41 5.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 75.43 110.853 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.26 161.42 49.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.682 0.753 . . . . 74.33 110.858 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -31.39 20.9 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.664 2.243 . . . . 63.32 112.359 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.21 -32.54 44.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.122 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.17 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 72.21 110.892 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.59 -165.76 33.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 65.02 112.55 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -173.58 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.66 2.24 . . . . 74.23 112.343 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -52.02 135.4 31.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.941 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -139.32 162.01 36.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 73.4 110.953 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.5 73.55 1.83 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.753 -0.737 . . . . 55.53 112.48 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.757 0.313 . . . . 75.24 110.886 -179.893 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.5 pt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.898 0.38 . . . . 71.5 111.093 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -52.26 114.44 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.885 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.7 t -110.96 32.41 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.43 110.884 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.27 161.35 49.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.697 0.76 . . . . 74.33 110.833 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.67 -31.39 21.01 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.646 2.23 . . . . 63.32 112.378 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.57 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 74.14 111.109 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.22 -30.79 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.21 110.86 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.54 -166.36 35.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 65.02 112.468 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 74.23 112.381 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -52.27 103.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 74.12 110.884 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -98.28 178.56 5.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 73.4 110.956 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.36 90.11 0.15 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 55.53 112.473 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.69 0.281 . . . . 75.24 110.885 -179.892 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 39.9 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.937 0.398 . . . . 71.5 111.192 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.2 t -82.51 114.52 20.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 62.32 110.9 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.0 p -111.14 32.31 5.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.44 49.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 74.33 110.892 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -31.35 20.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.728 2.285 . . . . 63.32 112.308 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.18 -32.52 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 74.14 111.078 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.72 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.893 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.97 -165.71 33.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 65.02 112.494 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 -173.19 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.699 2.266 . . . . 74.23 112.305 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -52.15 147.4 7.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.922 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -154.98 163.83 39.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 73.4 110.872 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.21 85.51 1.02 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.67 -0.776 . . . . 55.53 112.525 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 75.24 110.943 -179.883 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.4 pt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.888 0.375 . . . . 71.5 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.9 t -51.98 114.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 62.32 110.911 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t -111.05 32.32 5.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.875 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.38 49.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.552 0.692 . . . . 74.33 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.65 -31.31 21.28 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.781 2.321 . . . . 63.32 112.381 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.38 -32.43 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.059 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.76 71.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 72.21 110.903 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.36 -166.11 35.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 65.02 112.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -170.93 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.738 2.292 . . . . 74.23 112.352 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -52.01 103.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 74.12 110.872 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -98.3 177.88 5.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 73.4 110.94 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.16 90.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.739 . . . . 55.53 112.532 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 75.24 110.914 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.446 ' O ' HD12 ' A' ' 1' ' ' ILE . 1.2 pp . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.887 0.375 . . . . 71.5 111.139 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t -64.43 114.56 4.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 62.32 110.904 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.1 p -110.32 32.43 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.798 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.21 161.39 49.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.655 0.741 . . . . 74.33 110.897 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -31.21 20.65 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 63.32 112.32 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.42 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 74.14 111.065 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -30.86 71.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 72.21 110.82 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.8 -165.65 30.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 65.02 112.455 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.628 2.219 . . . . 74.23 112.356 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -52.06 135.13 31.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 74.12 110.839 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -139.87 171.79 13.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 73.4 110.878 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.25 74.87 2.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 55.53 112.508 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.341 . . . . 75.24 110.869 -179.866 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 27.7 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.817 0.341 . . . . 71.5 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t -86.05 114.53 23.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.923 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.8 p -110.26 32.28 5.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.882 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.16 161.57 48.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 74.33 110.914 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -31.13 20.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 2.253 . . . . 63.32 112.31 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.58 -32.51 36.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 74.14 111.13 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.77 71.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 72.21 110.861 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.46 -165.5 34.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 65.02 112.479 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.88 0.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.735 2.29 . . . . 74.23 112.408 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -51.91 143.56 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.326 -0.397 . . . . 74.12 110.93 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -143.65 172.5 12.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 73.4 110.906 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.37 -46.62 92.76 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.715 -0.755 . . . . 55.53 112.48 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 75.24 110.89 -179.858 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.926 0.393 . . . . 71.5 111.123 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t -66.32 114.59 5.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.888 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m -108.75 31.95 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.812 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.2 161.44 49.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 74.33 110.992 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.16 20.93 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 63.32 112.316 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.07 -32.55 30.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.14 111.057 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.19 -30.85 71.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.87 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.9 -165.35 30.64 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.792 -0.718 . . . . 65.02 112.519 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.268 . . . . 74.23 112.375 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -52.13 153.56 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 74.12 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -133.64 179.15 6.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 73.4 110.953 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.17 75.36 1.57 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.684 -0.77 . . . . 55.53 112.501 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 75.24 110.823 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 28.7 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.929 0.395 . . . . 71.5 111.146 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.65 114.49 23.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 62.32 110.909 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.3 p -108.86 32.28 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.908 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.11 161.62 48.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 74.33 110.846 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -30.96 21.49 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.711 2.274 . . . . 63.32 112.323 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.69 -32.45 28.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 74.14 111.03 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -30.92 71.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 72.21 110.869 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -165.19 34.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 65.02 112.453 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -170.82 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 74.23 112.333 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -51.76 135.55 29.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.878 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -133.24 166.09 23.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 73.4 110.912 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.64 77.77 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 55.53 112.514 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.0 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 75.24 110.891 -179.883 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.426 HG23 ' HE1' ' A' ' 11' ' ' TYR . 32.5 mm . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.852 0.358 . . . . 71.5 111.13 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.1 t -86.39 114.45 23.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 62.32 110.916 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 p -108.92 32.4 4.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.891 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.21 161.65 48.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.646 0.736 . . . . 74.33 110.88 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -30.94 21.76 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.718 2.279 . . . . 63.32 112.368 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.6 -32.36 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.101 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.32 -30.71 71.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 72.21 110.864 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 -165.04 34.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.737 . . . . 65.02 112.509 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -170.77 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.65 2.234 . . . . 74.23 112.349 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -51.87 135.91 29.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.902 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.426 ' HE1' HG23 ' A' ' 1' ' ' ILE . 4.7 t80 -132.89 166.91 21.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 73.4 110.925 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.76 77.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.759 -0.734 . . . . 55.53 112.456 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 75.24 110.856 -179.876 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.528 HG23 ' HE1' ' A' ' 11' ' ' TYR . 42.4 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.831 0.348 . . . . 71.5 111.149 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.5 t -85.78 114.44 22.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 62.32 110.912 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.0 p -108.86 32.41 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.838 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.17 161.73 48.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.611 0.719 . . . . 74.33 110.85 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -30.85 21.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 63.32 112.379 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.73 -32.51 27.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 74.14 111.092 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.845 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.5 -165.06 34.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 65.02 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -170.73 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 74.23 112.354 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -51.85 138.6 23.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 74.12 110.82 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.528 ' HE1' HG23 ' A' ' 1' ' ' ILE . 4.6 t80 -136.11 166.72 22.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 73.4 110.917 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.63 77.62 0.23 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 55.53 112.495 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.6 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 75.24 110.894 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.6 mm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.906 0.384 . . . . 71.5 111.175 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t -86.36 114.55 23.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 62.32 110.947 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -109.0 32.46 4.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.828 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.25 161.75 48.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.739 . . . . 74.33 110.899 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -31.08 21.52 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.742 2.295 . . . . 63.32 112.383 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.67 -32.32 28.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.14 111.082 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.41 -30.72 71.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 72.21 110.861 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.53 -164.96 34.29 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 65.02 112.444 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -170.88 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.663 2.242 . . . . 74.23 112.362 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -51.76 140.02 20.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.926 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.42 165.66 26.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.928 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.76 77.38 0.23 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 55.53 112.506 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.8 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 75.24 110.874 -179.878 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.869 0.366 . . . . 71.5 111.164 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.68 114.52 23.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 62.32 110.87 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.2 p -108.78 32.24 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.13 161.66 48.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.65 0.738 . . . . 74.33 110.881 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.92 21.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 63.32 112.313 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.79 -32.36 27.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 74.14 111.112 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.21 -30.91 71.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.894 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.22 -165.01 34.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 65.02 112.461 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.671 2.247 . . . . 74.23 112.346 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -51.86 133.67 31.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.85 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -131.75 163.2 28.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 73.4 110.976 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.68 79.26 0.27 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.724 -0.75 . . . . 55.53 112.5 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.4 p . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.319 . . . . 75.24 110.923 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.509 HG23 ' HE1' ' A' ' 11' ' ' TYR . 38.2 mm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.907 0.384 . . . . 71.5 111.114 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.6 t -84.36 114.41 21.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 62.32 110.881 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.4 p -108.14 31.81 5.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.927 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -85.94 162.07 48.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.586 0.708 . . . . 74.33 110.902 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -30.02 23.23 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.735 2.29 . . . . 63.32 112.325 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.62 -33.3 25.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.076 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -65.47 -30.88 71.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 72.21 110.864 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.67 -164.17 35.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 65.02 112.448 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 74.23 112.349 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -51.75 141.19 17.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.856 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.509 ' HE1' HG23 ' A' ' 1' ' ' ILE . 2.0 t80 -148.98 151.7 35.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 73.4 110.934 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.27 88.74 0.5 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 55.53 112.506 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 75.24 110.901 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.905 0.383 . . . . 62.32 110.879 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.5 p -111.35 32.26 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.34 49.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 74.33 110.92 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -31.39 20.84 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.694 2.263 . . . . 63.32 112.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 -32.56 47.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 74.14 111.067 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.26 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 72.21 110.891 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.77 -165.87 34.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 65.02 112.48 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -174.56 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.677 2.251 . . . . 74.23 112.35 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.891 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.8 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.874 0.369 . . . . 62.32 110.917 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.2 p -111.28 32.36 5.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.19 161.48 49.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.594 0.712 . . . . 74.33 110.945 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 -31.28 20.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 63.32 112.326 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.0 -32.38 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.086 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.35 -30.64 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.61 -166.75 33.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.773 -0.727 . . . . 65.02 112.523 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 74.23 112.389 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 74.12 110.934 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.2 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.891 0.377 . . . . 62.32 110.875 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.6 p -111.27 32.39 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.867 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.36 49.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 74.33 110.84 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -31.38 20.97 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.673 2.249 . . . . 63.32 112.382 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.97 -32.54 45.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 74.14 111.069 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.19 -30.86 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 72.21 110.861 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.35 -165.88 35.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 65.02 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -171.82 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.23 112.362 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.878 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.0 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.844 0.354 . . . . 62.32 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 t -111.17 32.3 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.43 110.883 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.17 161.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.727 . . . . 74.33 110.853 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -31.28 20.74 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.257 . . . . 63.32 112.394 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.06 -32.51 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.14 111.094 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.18 -30.78 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 72.21 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.51 -165.74 33.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 65.02 112.516 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -174.69 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.658 2.239 . . . . 74.23 112.285 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p30 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 74.12 110.922 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.852 0.358 . . . . 62.32 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.3 p -111.13 32.3 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 75.43 110.904 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -86.22 161.45 49.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 74.33 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.33 20.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 63.32 112.411 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.54 44.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.116 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 72.21 110.869 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.63 -165.88 33.65 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 65.02 112.52 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 -177.66 2.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.659 2.239 . . . . 74.23 112.351 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 74.12 110.923 179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.0 t . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.816 0.341 . . . . 62.32 110.84 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.9 t -111.03 32.22 5.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 75.43 110.867 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.09 161.34 49.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.7 0.762 . . . . 74.33 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -31.32 20.88 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.702 2.268 . . . . 63.32 112.37 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.43 44.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 74.14 111.155 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.39 -30.65 71.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 72.21 110.851 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.63 -165.95 32.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 65.02 112.468 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -171.49 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 74.23 112.347 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p30 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.975 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.8 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.924 0.393 . . . . 62.32 110.902 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 t -111.07 32.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.888 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.14 161.44 49.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 74.33 110.873 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.31 20.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 63.32 112.301 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.28 -32.48 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 74.14 111.075 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.21 -30.86 71.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 72.21 110.856 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.58 -165.7 32.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 65.02 112.482 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -173.42 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.637 2.224 . . . . 74.23 112.354 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.953 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.85 0.357 . . . . 62.32 110.841 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.5 p -111.09 32.41 5.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 75.43 110.853 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.26 161.42 49.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.682 0.753 . . . . 74.33 110.858 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -31.39 20.9 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.664 2.243 . . . . 63.32 112.359 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.21 -32.54 44.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.122 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.17 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 72.21 110.892 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.59 -165.76 33.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 65.02 112.55 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -173.58 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.66 2.24 . . . . 74.23 112.343 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.941 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.882 0.372 . . . . 62.32 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.7 t -110.96 32.41 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.43 110.884 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.27 161.35 49.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.697 0.76 . . . . 74.33 110.833 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.67 -31.39 21.01 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.646 2.23 . . . . 63.32 112.378 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.57 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 74.14 111.109 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.22 -30.79 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.21 110.86 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.54 -166.36 35.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 65.02 112.468 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 74.23 112.381 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 74.12 110.884 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.2 t . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.808 0.337 . . . . 62.32 110.9 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.0 p -111.14 32.31 5.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.44 49.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 74.33 110.892 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -31.35 20.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.728 2.285 . . . . 63.32 112.308 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.18 -32.52 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 74.14 111.078 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.72 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.893 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.97 -165.71 33.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 65.02 112.494 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 -173.19 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.699 2.266 . . . . 74.23 112.305 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.922 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.942 0.401 . . . . 62.32 110.911 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t -111.05 32.32 5.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.875 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.38 49.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.552 0.692 . . . . 74.33 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.65 -31.31 21.28 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.781 2.321 . . . . 63.32 112.381 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.38 -32.43 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.059 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.76 71.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 72.21 110.903 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.36 -166.11 35.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 65.02 112.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -170.93 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.738 2.292 . . . . 74.23 112.352 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 74.12 110.872 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.911 0.386 . . . . 62.32 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.1 p -110.32 32.43 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.798 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.21 161.39 49.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.655 0.741 . . . . 74.33 110.897 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -31.21 20.65 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 63.32 112.32 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.42 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 74.14 111.065 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -30.86 71.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 72.21 110.82 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.8 -165.65 30.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 65.02 112.455 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.628 2.219 . . . . 74.23 112.356 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 p30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 74.12 110.839 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.787 0.327 . . . . 62.32 110.923 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.8 p -110.26 32.28 5.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.882 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.16 161.57 48.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 74.33 110.914 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -31.13 20.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 2.253 . . . . 63.32 112.31 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.58 -32.51 36.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 74.14 111.13 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.77 71.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 72.21 110.861 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.46 -165.5 34.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 65.02 112.479 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.88 0.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.735 2.29 . . . . 74.23 112.408 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m120 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.326 -0.397 . . . . 74.12 110.93 179.974 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.824 0.345 . . . . 62.32 110.888 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m -108.75 31.95 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.812 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.2 161.44 49.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 74.33 110.992 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.16 20.93 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 63.32 112.316 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.07 -32.55 30.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.14 111.057 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.19 -30.85 71.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.87 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.9 -165.35 30.64 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.792 -0.718 . . . . 65.02 112.519 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.268 . . . . 74.23 112.375 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 74.12 110.865 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.831 0.348 . . . . 62.32 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.3 p -108.86 32.28 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.908 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.11 161.62 48.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 74.33 110.846 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -30.96 21.49 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.711 2.274 . . . . 63.32 112.323 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.69 -32.45 28.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 74.14 111.03 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -30.92 71.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 72.21 110.869 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -165.19 34.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 65.02 112.453 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -170.82 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 74.23 112.333 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.878 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.1 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.832 0.348 . . . . 62.32 110.916 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 p -108.92 32.4 4.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.891 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.21 161.65 48.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.646 0.736 . . . . 74.33 110.88 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -30.94 21.76 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.718 2.279 . . . . 63.32 112.368 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.6 -32.36 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.101 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.32 -30.71 71.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 72.21 110.864 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 -165.04 34.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.737 . . . . 65.02 112.509 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -170.77 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.65 2.234 . . . . 74.23 112.349 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.902 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.795 0.331 . . . . 62.32 110.912 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.0 p -108.86 32.41 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.838 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.17 161.73 48.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.611 0.719 . . . . 74.33 110.85 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -30.85 21.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 63.32 112.379 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.73 -32.51 27.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 74.14 111.092 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.845 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.5 -165.06 34.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 65.02 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -170.73 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 74.23 112.354 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 74.12 110.82 -179.967 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.938 0.399 . . . . 62.32 110.947 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -109.0 32.46 4.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.828 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.25 161.75 48.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.739 . . . . 74.33 110.899 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -31.08 21.52 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.742 2.295 . . . . 63.32 112.383 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.67 -32.32 28.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.14 111.082 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.41 -30.72 71.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 72.21 110.861 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.53 -164.96 34.29 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 65.02 112.444 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -170.88 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.663 2.242 . . . . 74.23 112.362 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.926 179.943 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.866 0.365 . . . . 62.32 110.87 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.2 p -108.78 32.24 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.13 161.66 48.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.65 0.738 . . . . 74.33 110.881 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.92 21.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 63.32 112.313 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.79 -32.36 27.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 74.14 111.112 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.21 -30.91 71.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.894 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.22 -165.01 34.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 65.02 112.461 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.671 2.247 . . . . 74.23 112.346 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.85 -179.976 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.885 0.374 . . . . 62.32 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.4 p -108.14 31.81 5.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.927 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -85.94 162.07 48.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.586 0.708 . . . . 74.33 110.902 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -30.02 23.23 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.735 2.29 . . . . 63.32 112.325 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.62 -33.3 25.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.076 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -65.47 -30.88 71.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 72.21 110.864 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.67 -164.17 35.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 65.02 112.448 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 74.23 112.349 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.856 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 56.1 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.898 0.38 . . . . 71.5 111.133 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.8 t -84.31 114.53 21.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 62.32 110.879 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.5 p -111.35 32.26 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.34 49.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.612 0.72 . . . . 74.33 110.92 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -31.39 20.84 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.694 2.263 . . . . 63.32 112.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 -32.56 47.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 74.14 111.067 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.26 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 72.21 110.891 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.77 -165.87 34.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 65.02 112.48 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -174.56 0.93 Allowed 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.677 2.251 . . . . 74.23 112.35 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -53.09 115.37 1.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 74.12 110.891 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -119.3 155.74 31.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 73.4 110.894 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.78 87.47 0.54 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.741 -0.742 . . . . 55.53 112.491 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 75.24 110.878 -179.904 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 31.9 mt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.843 0.354 . . . . 71.5 111.057 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.8 t -79.19 114.5 18.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 62.32 110.917 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.2 p -111.28 32.36 5.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.881 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.19 161.48 49.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.594 0.712 . . . . 74.33 110.945 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 -31.28 20.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 63.32 112.326 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.0 -32.38 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.086 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.35 -30.64 71.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.61 -166.75 33.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.773 -0.727 . . . . 65.02 112.523 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -171.57 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.694 2.263 . . . . 74.23 112.389 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -52.01 127.97 23.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 74.12 110.934 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -130.25 159.05 38.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.866 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.2 82.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 55.53 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.319 . . . . 75.24 110.891 -179.911 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.913 0.387 . . . . 71.5 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.2 t -84.03 114.52 21.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 62.32 110.875 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.6 p -111.27 32.39 5.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.867 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.36 49.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.63 0.729 . . . . 74.33 110.84 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 -31.38 20.97 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.673 2.249 . . . . 63.32 112.382 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.97 -32.54 45.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 74.14 111.069 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.19 -30.86 71.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 72.21 110.861 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.35 -165.88 35.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 65.02 112.518 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -171.82 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.23 112.362 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -52.19 114.96 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.878 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -119.63 169.93 9.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.834 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.16 88.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 55.53 112.479 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 75.24 110.907 -179.922 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 55.0 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.863 0.363 . . . . 71.5 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 37.0 t -76.9 114.46 15.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 62.32 110.923 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 t -111.17 32.3 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.43 110.883 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.17 161.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.626 0.727 . . . . 74.33 110.853 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -31.28 20.74 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.685 2.257 . . . . 63.32 112.394 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.06 -32.51 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.14 111.094 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.18 -30.78 71.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 72.21 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.51 -165.74 33.55 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 65.02 112.516 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -174.69 0.97 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.658 2.239 . . . . 74.23 112.285 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -52.11 116.12 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 74.12 110.922 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -100.21 171.43 7.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.49 . . . . 73.4 110.92 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.89 75.7 2.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.801 -0.714 . . . . 55.53 112.513 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 75.24 110.861 -179.876 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 37.5 mm . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.927 0.394 . . . . 71.5 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.7 t -84.72 114.57 22.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 62.32 110.893 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.3 p -111.13 32.3 5.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 75.43 110.904 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -86.22 161.45 49.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 74.33 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.33 20.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 63.32 112.411 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.08 -32.54 44.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.116 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.72 71.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 72.21 110.869 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 157.63 -165.88 33.65 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 65.02 112.52 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 -177.66 2.0 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.659 2.239 . . . . 74.23 112.351 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -51.97 118.88 3.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 74.12 110.923 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -121.1 162.83 19.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 73.4 110.925 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.18 77.18 1.71 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.776 -0.725 . . . . 55.53 112.503 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 75.24 110.834 -179.845 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 32.1 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.929 0.395 . . . . 71.5 111.145 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.0 t -77.05 114.5 15.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 62.32 110.84 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.9 t -111.03 32.22 5.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 75.43 110.867 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.09 161.34 49.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.7 0.762 . . . . 74.33 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -31.32 20.88 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.702 2.268 . . . . 63.32 112.37 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.43 44.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 74.14 111.155 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.39 -30.65 71.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 72.21 110.851 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.63 -165.95 32.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 65.02 112.468 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -171.49 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 74.23 112.347 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -52.21 116.52 2.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.975 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.94 171.66 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.886 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.3 61.61 4.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.781 -0.723 . . . . 55.53 112.512 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 75.24 110.845 -179.842 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.874 0.369 . . . . 71.5 111.211 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.8 t -83.32 114.58 21.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 62.32 110.902 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.7 t -111.07 32.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.888 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.14 161.44 49.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.618 0.723 . . . . 74.33 110.873 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.31 20.52 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 63.32 112.301 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.28 -32.48 43.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 74.14 111.075 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.21 -30.86 71.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 72.21 110.856 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.58 -165.7 32.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 65.02 112.482 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -173.42 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.637 2.224 . . . . 74.23 112.354 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -52.12 125.84 16.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -107.56 173.07 6.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 73.4 110.908 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.08 58.19 4.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.764 -0.731 . . . . 55.53 112.441 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.1 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.762 0.315 . . . . 75.24 110.857 -179.876 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.914 0.388 . . . . 71.5 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -74.9 114.47 13.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 62.32 110.841 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.5 p -111.09 32.41 5.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.443 . . . . 75.43 110.853 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.26 161.42 49.12 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.682 0.753 . . . . 74.33 110.858 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -31.39 20.9 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.664 2.243 . . . . 63.32 112.359 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.21 -32.54 44.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.122 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.17 -30.84 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 72.21 110.892 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.59 -165.76 33.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.802 -0.713 . . . . 65.02 112.55 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -173.58 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.66 2.24 . . . . 74.23 112.343 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -52.02 135.4 31.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.941 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -139.32 162.01 36.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 73.4 110.953 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.5 73.55 1.83 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.753 -0.737 . . . . 55.53 112.48 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.757 0.313 . . . . 75.24 110.886 -179.893 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.5 pt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.898 0.38 . . . . 71.5 111.093 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -52.26 114.44 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.885 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.7 t -110.96 32.41 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.43 110.884 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.27 161.35 49.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.697 0.76 . . . . 74.33 110.833 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.67 -31.39 21.01 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.646 2.23 . . . . 63.32 112.378 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.57 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 74.14 111.109 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.22 -30.79 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.21 110.86 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.54 -166.36 35.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 65.02 112.468 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.664 2.242 . . . . 74.23 112.381 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -52.27 103.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 74.12 110.884 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -98.28 178.56 5.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 73.4 110.956 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.36 90.11 0.15 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 55.53 112.473 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-O 120.69 0.281 . . . . 75.24 110.885 -179.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 39.9 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.937 0.398 . . . . 71.5 111.192 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 36.2 t -82.51 114.52 20.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 62.32 110.9 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.0 p -111.14 32.31 5.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.16 161.44 49.35 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 74.33 110.892 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -31.35 20.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.728 2.285 . . . . 63.32 112.308 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.18 -32.52 44.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 74.14 111.078 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.72 71.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.893 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.97 -165.71 33.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 65.02 112.494 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 -173.19 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.699 2.266 . . . . 74.23 112.305 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -52.15 147.4 7.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.922 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -154.98 163.83 39.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 73.4 110.872 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.21 85.51 1.02 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.67 -0.776 . . . . 55.53 112.525 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 75.24 110.943 -179.883 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.4 pt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.888 0.375 . . . . 71.5 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.9 t -51.98 114.53 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 62.32 110.911 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t -111.05 32.32 5.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.875 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.21 161.38 49.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.552 0.692 . . . . 74.33 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.65 -31.31 21.28 Favored 'Trans proline' 0 C--O 1.23 0.117 0 C-N-CA 122.781 2.321 . . . . 63.32 112.381 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.38 -32.43 43.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.059 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.25 -30.76 71.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 72.21 110.903 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.36 -166.11 35.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 65.02 112.485 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -170.93 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.738 2.292 . . . . 74.23 112.352 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -52.01 103.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 74.12 110.872 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -98.3 177.88 5.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 73.4 110.94 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.16 90.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.747 -0.739 . . . . 55.53 112.532 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 75.24 110.914 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.446 ' O ' HD12 ' A' ' 1' ' ' ILE . 1.2 pp . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.887 0.375 . . . . 71.5 111.139 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t -64.43 114.56 4.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 62.32 110.904 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.1 p -110.32 32.43 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.798 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -86.21 161.39 49.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.655 0.741 . . . . 74.33 110.897 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -31.21 20.65 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 63.32 112.32 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.54 -32.42 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 74.14 111.065 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.27 -30.86 71.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 72.21 110.82 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.8 -165.65 30.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 65.02 112.455 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.628 2.219 . . . . 74.23 112.356 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -52.06 135.13 31.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 74.12 110.839 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -139.87 171.79 13.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 73.4 110.878 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.25 74.87 2.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 55.53 112.508 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.341 . . . . 75.24 110.869 -179.866 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 27.7 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.817 0.341 . . . . 71.5 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.6 t -86.05 114.53 23.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.923 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.8 p -110.26 32.28 5.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.882 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.16 161.57 48.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 74.33 110.914 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.85 -31.13 20.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 2.253 . . . . 63.32 112.31 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.58 -32.51 36.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 74.14 111.13 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.32 -30.77 71.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 72.21 110.861 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.46 -165.5 34.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 65.02 112.479 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.88 0.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.735 2.29 . . . . 74.23 112.408 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -51.91 143.56 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.326 -0.397 . . . . 74.12 110.93 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -143.65 172.5 12.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 73.4 110.906 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.37 -46.62 92.76 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.715 -0.755 . . . . 55.53 112.48 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 75.24 110.89 -179.858 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.926 0.393 . . . . 71.5 111.123 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t -66.32 114.59 5.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.888 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.9 m -108.75 31.95 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.812 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.2 161.44 49.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 74.33 110.992 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -31.16 20.93 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 63.32 112.316 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.07 -32.55 30.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.14 111.057 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.19 -30.85 71.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.87 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.9 -165.35 30.64 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.792 -0.718 . . . . 65.02 112.519 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.268 . . . . 74.23 112.375 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -52.13 153.56 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 74.12 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -133.64 179.15 6.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 73.4 110.953 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.17 75.36 1.57 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.684 -0.77 . . . . 55.53 112.501 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 75.24 110.823 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 28.7 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.929 0.395 . . . . 71.5 111.146 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.65 114.49 23.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 62.32 110.909 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.3 p -108.86 32.28 5.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.908 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -86.11 161.62 48.93 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.593 0.711 . . . . 74.33 110.846 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -30.96 21.49 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.711 2.274 . . . . 63.32 112.323 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.69 -32.45 28.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 74.14 111.03 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -30.92 71.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 72.21 110.869 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.58 -165.19 34.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 65.02 112.453 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -170.82 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 74.23 112.333 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -51.76 135.55 29.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.878 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -133.24 166.09 23.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 73.4 110.912 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.64 77.77 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 55.53 112.514 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.0 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 75.24 110.891 -179.883 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.426 HG23 ' HE1' ' A' ' 11' ' ' TYR . 32.5 mm . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.852 0.358 . . . . 71.5 111.13 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.1 t -86.39 114.45 23.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 62.32 110.916 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 p -108.92 32.4 4.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.891 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.21 161.65 48.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.646 0.736 . . . . 74.33 110.88 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -30.94 21.76 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.718 2.279 . . . . 63.32 112.368 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.6 -32.36 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.101 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.32 -30.71 71.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 72.21 110.864 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.18 -165.04 34.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.737 . . . . 65.02 112.509 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -170.77 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.65 2.234 . . . . 74.23 112.349 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -51.87 135.91 29.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.902 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.426 ' HE1' HG23 ' A' ' 1' ' ' ILE . 4.7 t80 -132.89 166.91 21.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 73.4 110.925 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.76 77.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.759 -0.734 . . . . 55.53 112.456 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 75.24 110.856 -179.876 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.528 HG23 ' HE1' ' A' ' 11' ' ' TYR . 42.4 mt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.831 0.348 . . . . 71.5 111.149 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.5 t -85.78 114.44 22.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 62.32 110.912 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.0 p -108.86 32.41 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.838 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.17 161.73 48.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.611 0.719 . . . . 74.33 110.85 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -30.85 21.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 63.32 112.379 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.73 -32.51 27.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 74.14 111.092 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.845 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.5 -165.06 34.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 65.02 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -170.73 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 74.23 112.354 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -51.85 138.6 23.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 74.12 110.82 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.528 ' HE1' HG23 ' A' ' 1' ' ' ILE . 4.6 t80 -136.11 166.72 22.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 73.4 110.917 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.63 77.62 0.23 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 55.53 112.495 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.6 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 75.24 110.894 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.6 mm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.906 0.384 . . . . 71.5 111.175 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.4 t -86.36 114.55 23.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 62.32 110.947 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -109.0 32.46 4.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.828 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.25 161.75 48.16 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.651 0.739 . . . . 74.33 110.899 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -31.08 21.52 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.742 2.295 . . . . 63.32 112.383 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.67 -32.32 28.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.14 111.082 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.41 -30.72 71.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 72.21 110.861 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.53 -164.96 34.29 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 65.02 112.444 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -170.88 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.663 2.242 . . . . 74.23 112.362 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -51.76 140.02 20.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.926 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.42 165.66 26.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.928 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.76 77.38 0.23 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 55.53 112.506 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.8 p . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.756 0.312 . . . . 75.24 110.874 -179.878 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.869 0.366 . . . . 71.5 111.164 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.68 114.52 23.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 62.32 110.87 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.2 p -108.78 32.24 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.93 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.13 161.66 48.75 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.65 0.738 . . . . 74.33 110.881 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.92 21.41 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.701 2.267 . . . . 63.32 112.313 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.79 -32.36 27.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 74.14 111.112 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.21 -30.91 71.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.894 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.22 -165.01 34.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 65.02 112.461 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.671 2.247 . . . . 74.23 112.346 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -51.86 133.67 31.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.85 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -131.75 163.2 28.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 73.4 110.976 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.68 79.26 0.27 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.724 -0.75 . . . . 55.53 112.5 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.4 p . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.319 . . . . 75.24 110.923 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.509 HG23 ' HE1' ' A' ' 11' ' ' TYR . 38.2 mm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.907 0.384 . . . . 71.5 111.114 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.6 t -84.36 114.41 21.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 62.32 110.881 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.4 p -108.14 31.81 5.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 75.43 110.927 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -85.94 162.07 48.05 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.586 0.708 . . . . 74.33 110.902 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -30.02 23.23 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.735 2.29 . . . . 63.32 112.325 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.62 -33.3 25.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.076 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -65.47 -30.88 71.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 72.21 110.864 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.67 -164.17 35.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.714 -0.755 . . . . 65.02 112.448 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -170.84 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.703 2.269 . . . . 74.23 112.349 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -51.75 141.19 17.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.856 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.509 ' HE1' HG23 ' A' ' 1' ' ' ILE . 2.0 t80 -148.98 151.7 35.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 73.4 110.934 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.27 88.74 0.5 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 55.53 112.506 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 75.24 110.901 -179.883 . . . . . . . . 0 0 . 1 stop_ save_